Blood Transfusion Diagnostics Market Set to Reach USD 7.73 Billion by 2032, Driven by Rising Demand for Safe Transfusions and Advanced Screening Technologies – SNS Insider

SNS Insider Highlights the Growth Trajectory of the U.S. Blood Transfusion Diagnostics Market—Valued at USD 1.42 Billion in 2023—As the Country Dominates Global Demand Due to Widespread Use of Automated and Molecular Testing Technologies in Blood Screening.

Austin, July 02, 2025 (GLOBE NEWSWIRE) — Blood Transfusion Diagnostics Market Size & Growth Analysis:

According to SNS Insider, the global Blood Transfusion Diagnostics Market was valued at USD 4.61 billion in 2023 and is expected to reach USD 7.73 billion by 2032, expanding at a CAGR of 5.91% during the forecast period of 2024–2032.

The global blood transfusion diagnostics market is poised to witness steady growth over the forecast years, on account of increased demand for safe transfusions, rising prevalence of blood disorders, and increasing number of surgical and traumatic cases. Technology, especially in automation and molecular testing, enables more accurate and faster results, ultimately increasing the growth of the market.

Get a Sample Report of Blood Transfusion Diagnostics Market@ https://www.snsinsider.com/sample-request/2968

The U.S. blood transfusion diagnostics market was estimated at USD 1.42 billion in 2023 and is expected to reach USD 2.23 billion by 2032, at a CAGR of 5.17% during the forecast period of 2024-2032

Owing to the presence of advanced healthcare infrastructure, a high number of blood transfusion procedures, and the wide adoption of automated and molecular diagnostic technologies, the North American blood transfusion diagnostics market is dominated by the U.S.

Major Players Analysis Listed in this Report are:

• Illumina, Inc. (Verifi Prenatal Test, TruSight NIPT Solution)
• Thermo Fisher Scientific Inc. (Thermo Scientific Dako Blood Transfusion Kits, Thermo Scientific Invitrogen Immunoassays)
• Abbott Laboratories (Alinity’s System, PRISM HIV O Plus Assay)
• Grifols (Procleix Panther System, Grifols Blood Typing Reagents)
• Siemens Healthineers (ADVIA Centaur XP Immunoassay System, Atellica IM TSH)
• Roche Diagnostics (Cobas e 411 Analyzer, Roche Diagnostics Blood Transfusion Kits)
• Beckman Coulter, Inc. (Access 2 Immunoassay System, Coulter LH 750 Hematology Analyzer)
• Becton Dickinson and Company (BD Max System, BD Vacutainer Blood Collection Tubes)
• Ortho Clinical Diagnostics (Ortho Vision Analyzer, Ortho Workstation)
• Bio-Rad Laboratories, Inc. (BioPlex 2200, Bio-Rad Transfusion Diagnostic Systems)
• Akers Biosciences (The BreathScan Alcohol Breathalyzer, The Blood Typing Test)
• MacoPharma (Macotest Blood Typing, MacoBlood IV-Drug Test)
• F. Hoffmann-La Roche AG (Cobas 8000 Series, Roche Cobas Liat System)
• Sysmex Corporation (Sysmex XN-Series, Sysmex XN-31 Hematology Analyzer)
• Quidel Corporation (QuickVue Influenza A+B Test, QuickVue At-Home Test Kit)
• Abcam (Human Blood Typing Reagents, Hemoglobin Subunit Antibodies)
• BioMerieux (VIDAS Blood Culture System, BioFire FilmArray Blood Culture Panel)
• Sekisui Diagnostics (Sapphire Blood Typing, Immunoassay Panels)
• Diacor (Diacor Blood Typing Kits, Diacor Immunoassay Systems)
• Wako Pure Chemical Industries, Ltd. (Human Blood Coagulation Reagents, Blood Typing Reagents)

Blood Transfusion Diagnostics Market Report Scope

Report Attributes	Details
Market Size in 2023	US$ 4.61 billion
Market Size by 2032	US$ 7.73 billion
CAGR	CAGR of 5.91% From 2024 to 2032
Base Year	2023
Forecast Period	2024-2032
Historical Data	2020-2022
Regional Analysis	North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America)

Segment Analysis

By Product, the Reagents & Kits Segment Dominated the Blood Transfusion Diagnostics Market

In 2023, the blood transfusion diagnostics market was dominated by the reagents & kits segment with 65.23% market share, as they play a critical role in ensuring the safety and compatibility of blood transfusions. They have widespread applications used in blood grouping, antibody screening, infectious disease detection, and crossmatching. This ensures a steady demand for their use in routine testing of donors and recipients in hospitals, blood banks, and diagnostic laboratories.

Disease Screening Segment Led in the Blood Transfusion Diagnostics Market by Application

In 2023, the blood transfusion diagnostics market was dominated by the disease screening segment with 62.32% market share, with the need to monitor infectious agents that can infect the received blood playing a critical role in transfusion safety, such as HIV, Hepatitis B and C, syphilis, and malaria. Stringent screening of donated blood is mandated by regulatory bodies around the globe in order to mitigate the risk of the spread of such infections through blood transfusion.

Blood Banks Segment Dominated the Market by End-Use in The Blood Transfusion Diagnostics Market

The blood banks segment leads the market with 40.25% market share in 2023, due directly to their central role in the reception, identification, collection, testing, and distribution of donated blood to hospitals and outpatient clinics. Blood centers have the newest diagnostic equipment for screening of blood infections, blood grouping, and cross-matching for transfusion safety and compliance with regulatory standards. The need for blood and its components is increasing globally due to multiple trauma cases, surgeries, and chronic conditions, which have an impact on the growing number of examinations carried out in blood banks for the discovery and screening of infectious agents. The commitment to quality and other safety criteria has gained them a strong foothold in the sector.

For A Detailed Briefing Session with Our Team of Analysts, Connect with Us Now@ https://www.snsinsider.com/request-analyst/2968

Blood Transfusion Diagnostics Market Segmentation

By Product

• Reagents & kits
• Instruments
• Others

By Application

• Blood grouping
• Disease screening

By End-Use

• Hospitals
• Blood banks
• Diagnostics laboratories
• Others

North America to Account for the Highest Demand Share Globally, and the Asia-Pacific Region Anticipated to Record the Fastest Growth

The blood transfusion diagnostics market is dominated by North America with 40.46% market share in 2023, where the adoption of advanced healthcare infrastructure, the high prevalence of stringent regulations governing blood safety, and the adoption of high and mid-high automated blood transfusion diagnostics testing systems are some of the factors attributed to the growth of the blood transfusion diagnostics market.

The blood transfusion diagnostics market in Asia-Pacific is expected to grow at the fastest rate, owing to quick access to healthcare facilities, increased knowledge of blood safety, and a rise in the need for early detection of diseases throughout the predicted period. But China, India, and Southeast Asia are all pouring money into advancing the reach of blood screening.

Table of Contents – Major Key Points

1. Introduction

2. Executive Summary

3. Research Methodology

4. Market Dynamics Impact Analysis

5. Statistical Insights and Trends Reporting

6. Competitive Landscape

7. Blood Transfusion Diagnostics Market by Product

8. Blood Transfusion Diagnostics Market by Application

9. Blood Transfusion Diagnostics Market by End-Use

10. Regional Analysis

11. Company Profiles

12. Use Cases and Best Practices

13. Conclusion

Buy a Single-User PDF of Blood Transfusion Diagnostics Market Analysis & Outlook Report 2024-2032@ https://www.snsinsider.com/checkout/2968

About Us:

SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.

CONTACT: Contact Us:
Jagney Dave - Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: info@snsinsider.com

Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.